Noribogaine, but not 18‐MC, exhibits similar actions as ibogaine on GDNF expression and ethanol self‐administration
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Ibogaine is a naturally occurring alkaloid that has been reported to decrease various adverse phenotypes associated with exposure to drugs of abuse and alcohol in human and rodent models. Unfortunately, ibogaine cannot be used as a medication to treat addiction because of severe side effects. Previously, we reported that the desirable actions of ibogaine to reduce self‐administration of, and relapse to, alcohol consumption are mediated via the upregulation of the expression of the glial cell line‐derived neurotrophic factor (GDNF) in the midbrain ventral tegmental area (VTA), and the consequent activation of the GDNF pathway. The ibogaine metabolite, noribogaine, and a synthetic derivative of ibogaine, 18‐Methoxycoronaridine (18‐MC), possess a similar anti‐addictive profile as ibogaine in rodent models, but without some of its adverse side effects. Here, we determined whether noribogaine and/or 18‐MC, like ibogaine, increase GDNF expression, and whether their site of action to reduce alcohol consumption is the VTA. We used SH‐SY5Y cells as a cell culture model and found that noribogaine, like ibogaine, but not 18‐MC, induces a robust increase in GDNF mRNA levels. Next, we tested the effect of intra‐VTA infusion of noribogaine and 18‐MC on rat operant alcohol self‐administration and found that noribogaine, but not 18‐MC, in the VTA decreases responding for alcohol. Together, our results suggest that noribogaine and 18‐MC have different mechanisms and sites of action.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jhou, T. C., Fields, H. L., Baxter, M. G., Saper, C. B., & Holland, P. C. (2009) · Neuron · doi:10.1016/j.neuron.2009.02.001 · Cited by 696
Klink, R., d'Exaerde, A. D. K., Zoli, M., & Changeux, J.-P. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-05-01452.2001 · Cited by 674
Glick, S. D., Maisonneuve, I. M., Kitchen, B. A., & Fleck, M. W. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01284-0 · Cited by 122
Self-citationGLICK, S. D., MAISONNEUVE, I. M., & SZUMLINSKI, K. K. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb05211.x · Cited by 92 · cited 7×
“Unfortunately, despite its attractive properties, ibogaine is not used in the US to treat addiction because of severe side effects, which include hallucination, bradycardia, whole-body tremors and ataxia (Popik et al. 1995; Glick et al. 2000; Maas & Strubelt 2006; Alper et al. 2008; Maciulaitis et al. 2008).”
InfluentialSelf-citation
Cited by
A non-hallucinogenic psychedelic analogue with therapeutic potential
Cameron, L. P., Tombari, R. J., Lu, J., Pell, A. J., Hurley, Z. Q., Ehinger, Y., Vargas, M. V., McCarroll, M. N., Taylor, J. C., Myers-Turnbull, D., et al. (2021) · Nature · doi:10.1038/s41586-020-3008-z · Cited by 473
Intermittent ethanol access schedule in rats as a preclinical model of alcohol abuse
Carnicella, S., Ron, D., & Barak, S. (2014) · Alcohol · doi:10.1016/j.alcohol.2014.01.006 · Cited by 320
Self-citationBarsuglia, J. P., Polanco, M., Palmer, R., Malcolm, B. J., Kelmendi, B., & Calvey, T. (2018) · Progress in Brain Research · doi:10.1016/bs.pbr.2018.08.002 · Cited by 38
Mangini, P., Averill, L. A., & Davis, A. K. (2022) · Journal of Psychedelic Studies · doi:10.1556/2054.2021.00176 · Cited by 19
Metadata
- Authors
- Carnicella, S., He, D., Yowell, Q. V., Glick, S. D., & Ron, D.
- Venue
- Addiction Biology
- Publisher
- Wiley
- Published
- 2010-10
- Volume
- 15
- Issue
- 4
- Pages
- 424-433
- ISSN
- 1355-6215 (ISSN-L)
- 1369-1600
- OpenAlex
- W1602373301
- Cited by
- 47
- References
- 4
- FWCI
- 0.59
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Noribogaine, but not 18‐MC, exhibits similar actions as ibogaine on GDNF expression and ethanol self‐administration. https://app.cochat.ai/papers/10.1111/j.1369-1600.2010.00251.x
- The paper
- Carnicella, S., He, D., Yowell, Q. V., Glick, S. D., & Ron, D. (2010). Noribogaine, but not 18‐MC, exhibits similar actions as ibogaine on GDNF expression and ethanol self‐administration. Addiction Biology. https://doi.org/10.1111/j.1369-1600.2010.00251.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.